Risk factors
OmniAb (OABI) risk factors
Item 1A of every OmniAb, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors65 risks1 new1 dropped11 reworded
Revenue fell from $26.4 million to $18.7 million, while net losses widened from $62.0 million to $64.8 million.
Filed Mar 04, 2026 - FY2024 10-K risk factors65 risks
OmniAb faces substantial revenue concentration, with three partners generating 48% of 2024 revenue. The company operates at a continuing net loss, reporting $62.0 million in 2024. Success depends entirely on partners advancing platform-discovered therapeutics through clinical trials and regulatory approval.
Filed Mar 18, 2025